Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) released its financial results for Q2 FY22, ending October 2, 2021. The results are now available on their Investor Relations website. A conference call is scheduled for November 9, 2021, at 8:00 a.m. EST to discuss these results, accessible via a toll-free number and a live webcast. The earnings release and analytical tables have been posted online for investor review. For more details, visit their website.

BOSTON, Nov. 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2022, which ended October 2, 2021, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EST on November 9, 2021. The conference call and webcast can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 3529538
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/apntfy73

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 2Q FY22 Earnings Release:
https://haemonetics.gcs-web.com/static-files/97dd4f39-ebc7-4f1c-9058-dc2e6305d3c3 

Direct link to 2Q FY22 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/1f8f1f7d-24a0-46a4-8c34-20846dcc0a28

A replay of the conference call and webcast will be available for one year beginning on November 9, 2021 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact	Media Contact
Olga Guyette, Director-Investor Relations	Josh Gitelson, Director-Global Communications
(781) 356-9763	(781) 356-9776
olga.guyette@haemonetics.com	josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301419233.html

SOURCE Haemonetics Corporation

FAQ

What are the financial results for Haemonetics in Q2 FY22?

The financial results for Haemonetics for Q2 FY22 are now available on their Investor Relations website.

When is the Haemonetics conference call for Q2 FY22 results?

The conference call for Haemonetics' Q2 FY22 results is scheduled for November 9, 2021, at 8:00 a.m. EST.

How can I access the earnings release for Haemonetics?

The earnings release for Haemonetics can be accessed through their Investor Relations website.